Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors

Poorval Joshi(Mayo Clinic), Larry M. Karnitz(Mayo Clinic)
Journal of Biological Chemistry
February 20, 2014
Cited by 203


Related Papers